Showing results (1351-1360 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 3, 2007
Preferred drug lists and Medicaid prescriptionsTamer Abdelgawad, Lisa Egbuonu-DavisPharmacoeconomics|December 15, 2006
Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidolS Almond, O O'DonnellPharmacoeconomics|November 19, 2008
Single technology appraisals by NICE: are they delivering faster guidance to the NHS?Leela BarhamPharmacoeconomics|November 19, 2008
A cost-utility comparison of four first-line medications in painful diabetic neuropathyAlec B O'Connor, Katia Noyes, Robert G HollowayPharmacoeconomics|July 10, 2009
The future costs, risks and rewards of drug development: the economics of pharmacogenomicsJoseph Cook, Graeme Hunter, John A VernonPharmacoeconomics|July 10, 2009
The cost and impact of health conditions on presenteeism to employers: a review of the literatureAlyssa B Schultz, Chin-Yu Chen, Dee W EdingtonPharmacoeconomics|September 5, 2008
Subgroups and heterogeneity in cost-effectiveness analysisMark SculpherPharmacoeconomics|November 30, 2013
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studiesKatelijne van de Vooren, Silvy Duranti, Alessandro Curto, et al.Pharmacoeconomics|November 30, 2013
Cost effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in post-menopausal women with early-stage estrogen or progesterone-receptor-positive, axillary lymph-node positive breast cancerMalek B Hannouf, Bin Xie, Muriel Brackstone, et al.Pharmacoeconomics|October 16, 2013
The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countriesZaheer-Ud-Din Babar, Charon Lessing, Cécile Mace, et al.Pageof 336